44 results
Page 2 of 3
6-K
EX-99.2
igc3oorjih56svwv
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.3
n070f
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
0nupf66n wobiqdu
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
ecq4sycvf9 srgv
19 Feb 21
Pipeline and capital for growth
6:00am
6-K
EX-99.1
kh71kzznsowmc6bj1j3
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.2
zsgjcxf0q3 v946im
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.2
c03as8u1ot 45x8k
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
rjs6ya
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.2
4yjyxyu
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.1
y62d3ee8wx4
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.2
fxr5w4q6
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.3
mna3zep4 lou1i
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.2
ad794pkm j5mzw
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99
lsxhi
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.2
sp44m 82n8y15de
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm